Botulinum Toxin Type A for Forehead Rejuvenation: Clinical Evaluation and Treatment Outcomes

Facial aging is a progressive and multifactorial process characterized by the development of folds, ridges, and wrinkles resulting from structural and functional decline within the skin. Forehead rhytides are among the earliest and most prominent manifestations of facial aging and are primarily caused by repetitive contraction of the frontalis muscle. Botulinum toxin type A is widely used for the management of dynamic facial rhytides through localized chemodenervation and reduction of excessive muscle activity. Appropriate patient selection, anatomical assessment, individualized treatment planning, and precise injection technique are essential for achieving balanced and satisfactory outcomes while minimizing complications. Clinical assessment includes evaluation of the forehead at rest and during active facial expression, standardized photography, wrinkle-severity grading, and assessment of frontalis muscle activity. Treatment involves appropriate botulinum toxin formulation and preparation, precise injection-site selection, post-procedure care, and follow-up. Botulinum toxin provides a minimally invasive and predictable approach for the management of dynamic forehead rhytides, with rapid onset of action, low downtime, and high patient satisfaction.

 Botulinum toxin type A, forehead rhytides, facial rejuvenation, frontalis muscle, dynamic wrinkles 

 Volume: 19
Issue: 8
Published: September 2026